Dipyridamole (DP), a pyrimido-pyrimidine derivative, was found to be an interferon (IFN) inducer in cultivated in vitro lymphoid cells, and when given orally to mice and humans, it produced high IFN titres in less than 24 hours. A duration of IFN antagonistic activity was observed. The inducer target was...